Deferoxamine Plus Chemotherapy for Metastatic Triple Negative Breast Cancer
Status:
Recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to evaluate the efficacy and safety of chemotherapy plus
deferoxamine in metastatic breast cancer whose evaluation is stable disease with a trend of
progression.